Preparations of insulin (intradermal, intranasal, and oral) have not been able to prevent diabetes onset in those at risk and those having islet autoantibodies [85,86,87]; however, higher doses of oral insulin may have effects in those genetically at risk for T1D prior to the development of autoantibodies [88,89]. Here, INS is linked to type 1 diabetes mellitus.